on 18 Feb 2020
Last Applicant/ Owned by
230 Park Avenue, Suite 3350
New York
NY
10169
Serial Number
88320074 filed on 28th Feb 2019
Registration Number
5988021 registered on 18th Feb 2020
Correspondent Address
Andrew N. Spivak
Filing Basis
1. intent to use
Disclaimer
NO DATA
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services,Read More
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis services relating to the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of antibodies, and research and design relating thereto; industrial analysis and research services in the field of antibodies
No 88320074
No Service Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 18th Feb 2020 | REGISTERED-PRINCIPAL REGISTER |
| 15th Jan 2020 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 15th Jan 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 05th Dec 2019 | NOTICE OF ALLOWANCE CANCELLED |
| 05th Dec 2019 | TEAS DELETE 1(B) BASIS RECEIVED |
| 03rd Dec 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 08th Oct 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Oct 2019 | PUBLISHED FOR OPPOSITION |
| 18th Sep 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Sep 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
